OpenOutcrier
Posted - 3 days ago
$IMNM (+6.5% pre) Immunome to Present Poster Highlighting Preclinical Evaluation of IM-1021, a ROR1-Targeted Antibody Drug Conjugate, at the 36th EORTC-NCI-AACR Symposium - SI https://ooc.bz/l/45128
Skrumpa
Posted - 1 week ago
$IMNM Short at 12.22 Cover Stop at $11.54
Jeff9905
Posted - 1 week ago
$IMNM more and more postings for high level scientists. Is retail that stupid to sell now? Crazy.
Jeff9905
Posted - 1 week ago
$IMNM this is awesome news. Employee count above 110 and they are still aggressively hiring. Only idiots sell here.
OpenOutcrier
Posted - 1 week ago
$IMNM (-1.5% pre) Immunome Inc. (IMNM) Files for 230.4K Share Offering by Selling Stockholders - SI https://ooc.bz/l/44303
DonCorleone77
Posted - 1 week ago
$IMNM Immunome files to sell 230K shares of common stock for holders The company is not selling any common stock pursuant to this prospectus, and will not receive any proceeds from the sale of its common stock offered by this prospectus by the selling stockholder.
Fast_Eddie_Felson
Posted - 2 weeks ago
$IMNM looking like shit
apatbeck79
Posted - 2 weeks ago
$ZNTL only 547 watchers here. When news comes and this moves this will go 2200 watchers and will fly with the short covering. Most are in between 10-20.00. They will get it back there with the right news. Don’t forget over 420 million cash and stock in $IMNM
uberkauft
Posted - 2 weeks ago
$IMNM Immunovant, Inc. 14-Day RSI: 41.9 % from 52-Week Low: +93.8% % from 52-Week High: -56.6% Open Interest: 6,581 % Change: 0% Put/Call Ratio: 0.14 % Change: -2.8%
Dave24689990
Posted - 2 weeks ago
$IMNM on watch
oldpoorboy
Posted - 2 weeks ago
@BioStick123 @CH_Expat priority review designation may only scare the short sellers and make them cover. Not much movement. So I would not invest solely based on the designation. I'm in it for the long game, say early - mid 2025. Another one I'm balls deep is $IMNM
vu_jade
Posted - 09/30/24
$IMNM still a decent entry
Biotech2424
Posted - 09/23/24
$MNPR It’s Possible Monopar could get a deal for their pre clinical actinium asset. Or who knows maybe they get snapped up right now for $100 million. The lutetium mnpr-101 with phase 1/2 could be worth close to a billion.
$ADCT $IMNM $PYXS
Jeff9905
Posted - 09/23/24
$IMNM they are posting lots of job openings. Assuming this is a good thing?
Night_Owl_Biotech
Posted - 1 month ago
It would be humbly appreciated if someone with clinical expertise would kindly publish a genuine/unbiased comparison of the updated AL102 Phase 2 data from $IMNM presented at ESMO last weekend to Ogsiveo's like clinical profile ($SWTX). Thank you.
apatbeck79
Posted - 1 month ago
@Hendry884 of course but that doesn’t mean we won’t be getting to at least 6-8 just on potential and cash and stock they own in $IMNM And by that time. I’ll be almost phased out but will
Hold some just in case it hits the gold
apatbeck79
Posted - 1 month ago
$ZNTL people need to read the latest earnings and cash report and the amount of share they own in $IMNM Undervalued it’s scary here. I have loaded 48,000 shares $ALT is my other play. Just made 233k on $LUNR and $LUNRW Sold out completely just now on that one
Johnuser541
Posted - 1 month ago
$IMNM any news how the poster went over the weekend?
vikingforthewin
Posted - 1 month ago
$IMNM sus
Stock_Titan
Posted - 1 month ago
$IMNM Immunome to Present Updated Results for RINGSIDE Phase 2 Trial of AL102 for the Treatment of Desmoid Tumors at the European Society for Medical Oncology (ESMO) Congress 2024
https://www.stocktitan.net/news/IMNM/immunome-to-present-updated-results-for-ringside-phase-2-trial-of-yb1nqmmff5om.html
Putz20
Posted - 1 month ago
@Biotech2424 you think $imnm going to buy them?
Biotech2424
Posted - 1 month ago
$IMNM Buy as much Vincerx as you can!!!
SeekingOctane
Posted - 1 month ago
$GPCR Put NeuroBo on your watchlist Tiny 1 million share float Smoking hot 3rd gen obesity drug
Profitable biotech owns most of company Nrbo $IMNM $LVTX
stevelue
Posted - 1 month ago
$AZN $STRO $IMNM $CCCC $VINC
Fast_Eddie_Felson
Posted - 1 month ago
$IMNM no one gives two fucks about VINC , whats with the retards who keep posting this shit on here..stay on topic
ST shouldn’t even allow cross posting its a waste of time scrolling past that garbage
SeekingOctane
Posted - 1 month ago
$VINC AstraZeneca bought Hamdy’s last biotech for $7 billion. Now $AZN might be a natural fit for Vincerx novel adc platform. They are building a $1.5 billion dollar ADC manufacturing facility in Singapore.
$STRO $IMNM $CCCC
Night_Owl_Biotech
Posted - 08/29/24
We are unaware of any direct comparison of $SWTX 's Ogsiveo, aka nirogacestat, versus $IMNM 's (was $ADXS) AL102. Attached see copies of ASCO presentations side by side (SWTX from 6/2/22 & AL102 from 5/31/23) We're not qualified to comment on the Phase 2 presentations at ASCO & own considerable SWTX. However, we'd note only 10 of the 42 patients enrolled in the AL102 Phase 2 trial voluntarily opted to continue in AL102's open label extension at the end of the Phase 2 trial (where the patient continues to receive the drug for free). This was well before Ogsiveo was approved & commercially available. We find this data point telling because it suggests 32 of 42 of these patients were not feeling a benefit (despite the ORR & DCR data points). Of course we could be interpreting this incorrectly so if we are wrong please note why in the comments. We're not bashing AL102 but highlighting SWTX. Differences in time on treatment is also interesting. Genuine comments welcome.
Vic05
Posted - 08/29/24
$IMNM Conference next week should blow this thing up. Shorts only covered 1M
